1066P - Combination of a Novel Oncolytic Immunotherapeutic Agent, Coxsackievirus A21 and Pd-1 Blockade Significantly Reduces Tumor Growth and Improves Survival in an Immune Competent Mouse Melanoma Model

Autor: Shafren, D., Quah, M., Wong, Y., Andtbacka, R.H., Au, G.
Zdroj: In Annals of Oncology September 2014 25 Supplement 4:iv367-iv367
Databáze: ScienceDirect